Osborne Partners Capital Management buys $7,427,746 stake in Stericycle Inc (SRCL)

Stericycle Inc (SRCL) : Osborne Partners Capital Management scooped up 1,795 additional shares in Stericycle Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Jul 19, 2016. The investment management firm now holds a total of 69,731 shares of Stericycle Inc which is valued at $7,427,746.Stericycle Inc makes up approximately 1.07% of Osborne Partners Capital Management’s portfolio.

Other Hedge Funds, Including , Eagle Asset Management Inc boosted its stake in SRCL in the latest quarter, The investment management firm added 5,966 additional shares and now holds a total of 41,399 shares of Stericycle Inc which is valued at $4,409,821. Stericycle Inc makes up approx 0.03% of Eagle Asset Management Inc’s portfolio. Anderson Hoagland Co sold out all of its stake in SRCL during the most recent quarter. The investment firm sold 25,205 shares of SRCL which is valued $2,684,837.Arcadia Investment Management Corpmi reduced its stake in SRCL by selling 690 shares or 3.04% in the most recent quarter. The Hedge Fund company now holds 21,971 shares of SRCL which is valued at $2,325,850. Stericycle Inc makes up approx 0.73% of Arcadia Investment Management Corpmi’s portfolio.Next Financial Group Inc boosted its stake in SRCL in the latest quarter, The investment management firm added 860 additional shares and now holds a total of 910 shares of Stericycle Inc which is valued at $95,277. Stericycle Inc makes up approx 0.03% of Next Financial Group Inc’s portfolio.

Stericycle Inc opened for trading at $106.5 and hit $106.98 on the upside on Wednesday, eventually ending the session at $106.52, with a gain of 0.14% or 0.15 points. The heightened volatility saw the trading volume jump to 6,38,473 shares. Company has a market cap of $9,045 M.

On the company’s financial health, Stericycle Inc reported $1.11 EPS for the quarter, missing the analyst consensus estimate by $ -0.02 based on the information available during the earnings call on Apr 28, 2016. Analyst had a consensus of $1.13. The company had revenue of $874.20 million for the quarter, compared to analysts expectations of $869.95 million. The company’s revenue was up 31.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.08 EPS.

Many Wall Street Analysts have commented on Stericycle Inc. Company shares were Reiterated by Imperial Capital on May 26, 2016 to “In-line”, Firm has raised the Price Target to $ 100 from a previous price target of $95 .Shares were Reiterated by Wedbush on May 9, 2016 to “Neutral” and Lowered the Price Target to $ 100 from a previous price target of $112 .Shares were Reiterated by Imperial Capital on May 2, 2016 to “In-line” and Lowered the Price Target to $ 95 from a previous price target of $115 .

Stericycle Inc. is engaged in the business of providing regulated and compliance solutions to healthcare and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal and a variety of training consulting recall/return communication and compliance services which include training consulting inbound/outbound communications data reporting and other regulatory compliance services. The Company operates regulated waste management networks in the United States Argentina Brazil Canada Chile Ireland Japan Mexico Portugal Romania South Korea Spain and the United Kingdom. The Company operates through two segments: United States and International. The Company’s networks include a total of 181 processing facilities 214 transfer sites and 97 other service facilities. Its regulated waste processing technology is primarily autoclaving. The Company also uses incineration and electro-thermal-deactivation system (ETD).

Leave a Reply

Stericycle Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Stericycle Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.